High Purity Tirzepatide Peptide Powder 5mg/10mg/15mg/30mg CAS 2023788-19-2

Tirzepatide is a synthetic peptide that functions as a dual agonist of GIP and GLP-1 receptors, originally developed to support metabolic regulation. Supplied in lyophilized powder form in 5mg, 10mg, 15mg, and 30mg vials, this compound is strictly intended for laboratory research use. Each vial is manufactured under GMP-compliant conditions to ensure high purity, consistent quality, and reliable results in experimental settings.

Key Features:

Available in 5mg, 10mg, 15mg, and 30mg dosages

CAS Number: 2023788-19-2

Dual GIP and GLP-1 receptor agonist

Lyophilized powder in sterile glass vials

For research and laboratory use only

High purity (>99%) tested by HPLC/MS

Tirzepatide vials contain a medication used primarily for the treatment of type 2 diabetes and chronic weight management. The active ingredient, tirzepatide, is a dual incretin receptor agonist that mimics the effects of two natural gut hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).

1. Improves Blood Sugar Control:
Stimulates insulin secretion in response to high blood sugar.
Reduces glucagon levels, which helps lower blood glucose.

2. Promotes Weight Loss:
Suppresses appetite and reduces food intake.
Delays gastric emptying, helping patients feel fuller for longer.

3. Supports Weekly Dosing:
Tirzepatide is administered once a week, providing convenient and sustained blood sugar and weight management.

4. Used in Obese or Overweight Adults:
Particularly beneficial for adults with obesity or overweight who have at least one weight-related health condition, such as high blood pressure or high cholesterol.